The Activities of Current Antimalarial Drugs on the Life Cycle Stages of : A Comparative Study with Human and Rodent Parasites

English version České info

Background:
Malaria remains a disease of devastating global impact, killing more than 800,000 people every year—the vast majority being children under the age of 5. While effective therapies are available, if malaria is to be eradicated a broader range of small molecule therapeutics that are able to target the liver and the transmissible sexual stages are required. These new medicines are needed both to meet the challenge of malaria eradication and to circumvent resistance.

Methods and Findings:
Little is known about the wider stage-specific activities of current antimalarials that were primarily designed to alleviate symptoms of malaria in the blood stage. To overcome this critical gap, we developed assays to measure activity of antimalarials against all life stages of malaria parasites, using a diverse set of human and nonhuman parasite species, including male gamete production (exflagellation) in Plasmodium falciparum, ookinete development in P. berghei, oocyst development in P. berghei and P. falciparum, and the liver stage of P. yoelii. We then compared 50 current and experimental antimalarials in these assays. We show that endoperoxides such as OZ439, a stable synthetic molecule currently in clinical phase IIa trials, are strong inhibitors of gametocyte maturation/gamete formation and impact sporogony; lumefantrine impairs development in the vector; and NPC-1161B, a new 8-aminoquinoline, inhibits sporogony.

Conclusions:
These data enable objective comparisons of the strengths and weaknesses of each chemical class at targeting each stage of the lifecycle. Noting that the activities of many compounds lie within achievable blood concentrations, these results offer an invaluable guide to decisions regarding which drugs to combine in the next-generation of antimalarial drugs. This study might reveal the potential of life-cycle–wide analyses of drugs for other pathogens with complex life cycles.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: The Activities of Current Antimalarial Drugs on the Life Cycle Stages of : A Comparative Study with Human and Rodent Parasites. PLoS Med 9(2): e32767. doi:10.1371/journal.pmed.1001169
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001169

Souhrn

Zdroje

1. World Health Organization 2010 World malaria report. Available: http://www.who.int/malaria/world_malaria_report_2010/en/. Accessed 6 December 2011

2. Medicines for Malaria Venture (MMV) 2010 MMV target product profiles. Available: http://www.mmv.org/research-development/essential-information-scientists/target-product-profiles. Accessed 5 December 2011

3. FidockDA 2010 Drug discovery: priming the antimalarial pipeline. Nature 20 297 298

4. WellsTNCAlonsoPLGutteridgeWE 2009 New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov 8 879 891

5. SindenRE 2010 A biologist's perspective on malaria vaccine development. Hum Vaccin 6 3 11

6. GreenwoodBMFidockDAKyleDEKappeSHIAlonsoPL 2008 Malaria: progress, perils, and prospects for eradication. J Clin Invest 118 1266 1276

7. BakerDA 2010 Malaria gametocytogenesis. Mol Biochem Parasitol 172 57 65

8. SindenRETalmanAMarquesSRWassMNSternbergMJ 2010 The flagellum in malarial parasites. Curr Opin Microbiol 13 491 500

9. VinetzJM 2005 Plasmodium ookinete invasion of the mosquito midgut. Curr Top Microbiol Immunol 295 357 382

10. PiyaphaneeWKrudsoodSTangpukdeeNThanachartwetWSilachamroonU 2006 Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 74 432 435

11. StepniewskaKPriceRNSutherlandCJDrakeleyCJvon SeidleinL 2008 Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J 7 249

12. BousemaTOkellLShekalagheSGriffinJTOmarS 2010 Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J 9 136

13. CoulibalyBZoungranaAMockenhauptFPSchirmerRHKloseC 2009 Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS One 4 e5318 doi:10.1371/journal.pone.0005318

14. ShekalagheSDrakeleyCGoslingRNdaroAvan MeegerenM 2007 Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One 2 e1023 doi:10.1371/journal.pone.0001023

15. HallettRLSutherlandCJAlexanderNOrdRJawaraM 2004 Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. Antimicrob Agents Chemother 48 3940 3943

16. ButcherGA 1997 Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27 974 987

17. KonAvan de Vegte-BolmerMSiebelink-StoterRvan GemertGJDaraA 2010 Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol 40 1221 1228

18. ColemanRE 1990 Sporontocidal activity of the antimalarial WR-238605 against Plasmodium berghei ANKA in Anopheles stephensi. Am J Trop Med Hyg 42 196 205

19. JanseCJFranke-FayardBMairGRRamesarJThielC 2006 High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol Biochem Parasitol 145 60 70

20. DawesEJZhuangSSindenREBasáñezM 2009 The temporal dynamics of Plasmodium density through the sporogonic cycle within Anopheles mosquitoes. Trans R Soc Trop Med Hyg 103 1197 1198

21. Franke-FayardBTruemanHRamesarJMendozaJvan der KeurM 2004 A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol 137 23 33

22. SindenRE 1997 Infection of mosquitoes with rodent malaria. Molecular biology of insect disease vectors: a methods manual. CramptonJMBeardCBLouisC London; New York Chapman and Hall 67 91

23. TragerWJensenJB 1976 Human malaria parasites in continuous culture. Science 193 673 675

24. KaushalDCCarterRMillerLHKrishnaG 1980 Gametocytogenesis by malaria parasites in continuous culture. Nature 286 490 492

25. VennerstromJLArbe-BarnesSBrunRCharmanSAChiuFC 2004 Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430 900 904

26. SindenREHartleyRHWingerL 1985 The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic division. Parasitology 91 227 244

27. ToyéPJSindenRECanningEU 1977 The action of metabolic inhibitors on microgametogenesis in Plasmodium yoelii nigeriensis. Z Parasitenkd 53 133 141

28. AlaviYAraiMMendozaJTufet-BayonaMSinhaR 2003 The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti. Int J Parasitol 33 933 943

29. DelvesMJSindenRE 2010 A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malar J 9 35

30. CarterRRanford-CartwrightLAlanoP 1993 The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies. Methods Mol Biol 21 67 88

31. MeisterSPlouffeDMKuhenKLBonamyGMCWuT 2011 Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334 1372 1377

32. ShinSCVanderbergJPTerzakisJA 1982 Direct infection of hepatocytes by sporozoites of Plasmodium berghei. J Protozool 29 448 454

33. MotaMMRodriguezA 2004 Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host. Cell Microbiol 6 1113 1118

34. MuJMyersRAJiangHLiuSRicklefsS 2010 Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet 42 268 271

35. WhiteNC 1997 Assessment of the pharmacodynamics properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41 1413 1422

36. DondorpAMFanelloCIHendriksenICEGomesESeniA 2010 Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376 1647 1657

37. O'NeillPMBartonVEWardSA 2010 The molecular mechanism of action of artemisinin—the debate continues. Molecules 15 1705 1721

38. KlonisNCrespo-OrtizMPBottovaIAbu-BakarNKennyS 2011 Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc Natl Acad Sci U S A 108 11405 11410

39. BhisutthibhanJPanXHosslerPAWalkerDJYowellCA 1998 The plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J Biol Chem 273 16192 16198

40. KumuraNFurukawaHOnyangoANIzumiMNakajimaS 2009 Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. Chem Phys Lipids 160 114 120

41. WellsTNCBurrowsJNBairdJK 2009 Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends in Parasitol 26 145 151

42. GerbergEJ 1971 Evaluation of antimalarial compounds in mosquito test systems. Trans R Soc Trop Med Hyg 65 358 363

43. BillkerOLindoVPanicoMAEtienneEAPaxtonT 1998 Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature 392 289 292

44. FowlerREBillingsleyPFPudneyMSindenRE 1994 Inhibitory action of the anti-malarial compound atovaquone (566C80) against Plasmodium berghei ANKA in the mosquito, Anopheles stephensi. Parasitology 108 383 388

45. FowlerRESindenREPudneyM 1995 Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts, and sporozoites of Plasmodium berghei. J Parasitol 81 452 458

46. BoysenKEMatuschewskiK 2011 Arrested oocyst maturation in Plasmodium parasites lacking type II NADH:ubiquininone dehydrogenase. J Biol Chem 286 32661 32671

47. PetersW 1987 Chemotherapy and drug resistance in malaria. Volume 1, 2nd edition London Academic Press

48. MoehrleJJArbe-BarnesSSiethoffCCraftJCDuparcS 2010 Novel synthetic ozonide OZ439: tolerability and pharmacokinetics in healthy volunteers. American Society of Tropical Medicine and Hygiene; November 3–7, 2010; Atlanta (Georgia, US); poster 1244. Available: http://www.astmh.org/AM/Template.cfm?Section=Abstracts_and_Education1&Template=/CM/ContentDisplay.cfm&ContentID=2847. Accessed 5 December 2011

49. McGreadyRStepniewskaKLindegardhNAshleyEALaY 2006 The pharmacokinetics of artemether and lumefantrine in pregnant woman with uncomplicated falciparum malaria. Eur J Clin Pharmacol 62 1021 1031

50. RamharterMKurthFSchreierACNemethJvon GlasenappI 2008 Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis 198 911 919

51. ChinhNTQuangNNThanhNXDaiBTraversT 2008 Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects. Am J Trop Med Hyg 79 620 623

52. NyuntMMAdamIKayentaoKvan DijkJThumaP 2010 Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther 87 226 234

53. SabchareonAAttanathPPhanuaksookPChanthavanichPPoonpanichY 1998 Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 92 201 206

54. LeeSJMcGreadyRFernandezCStepniewskaKPawMK 2008 Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Eur J Clin Pharmacol 64 987 992

55. RijkenMJMcGreadyRJullienVTarningJLindegardhN 2011 Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. Antimicrob Agents Chemother 55 4338 4342

56. WilairatanaPTangpukdeeNKrudsoodS 2010 Long term primaquine administration to reduce Plasmodium falciparum gametocyte transmission in hypoendemic areas. Southeast Asian J Trop Med Public Health 41 1306 1311

57. BartonVFisherNBiaginiGAWardSAO'NeillPM 2010 Inhibiting Plasmodium cytochrome bc1: a complex issue. Curr Opinion in Chem Biol 14 440 446

58. HoghBGamage-MendisAButcherGAThompsonRBegtrupK 1998 The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg 58 176 182

59. SinghAWalkerKJSijwaliPSLauALRosenthalPJ 2007 A chimeric cysteine protease of Plasmodium berghei engineered to resemble the Plasmodium falciparum protease falcipain-2. Protein Eng Des Sel 20 171 177

60. SinghAShenaiBKChoeYGutJSijwaliPS 2002 Critical role of amino acid 23 in mediating activity and specificity of vinckepain-2, a papain-family cysteine protease of rodent malaria parasites. Biochem J 368 273 281

61. DouglasNMAnsteyNMAngusBJNostenFPriceRN 2010 Artemisinin combination therapy for vivax malaria. Lancet Infect Dis 10 405 416

62. KockenCvan der WelAArbe-BarnesSBrunRMatileH 2006 Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75. Exp Parasitol 113 197 200

63. LuxDPrajakwongSKollaritschHWernsdorferGWernsdorferWH 2003 In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. Wien Klin Wochenschr 115 50 54

64. PriceRMarfurtJChalfeinFKenangalemEPieraKA 2010 In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrob Agents Chemother 54 5146 5150

65. TreiberMWernsdorferGWiedermannUCongpuongKSirichaisinthopJ 2011 Sensitivity of Plasmodium vivax to chloroquine, mefloquine, artemisinin and atovaquone in north-western Thailand. Wien Klin Wochenschr 123 Suppl 1 20 25

66. RussellBMUdomsangpetchRRieckmannKHKoteckaBMColemanRE 2003 Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother 47 170 173

67. LuFGaoQChotivanichKXiaHCaoJ 2011 In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Am J Trop Med Hyg 85 197 201

68. NostenFWhiteNJ 2007 Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg 77 181 192